08048035996
Leading exporter of Genuine MYCOMUNE S 360MG Tablets from India to Singapore - Tampines | Phoenix Ex

1. General Information

MYCOMUNE-S 360 MG Tablet is an immunosuppressive medicine containing mycophenolate sodium 360 mg. It reduces certain immune-system responses that can cause the body to attack a transplanted organ. It is primarily used as part of an immunosuppressive treatment regimen following organ transplantation.

The medicine is generally prescribed together with other immunosuppressive medicines according to the patient's transplant protocol.

2. Product Information

  • Brand Name: MYCOMUNE-S 360 MG
  • Active Ingredient: Mycophenolate sodium 360 mg
  • Dosage Form: Tablet
  • Therapeutic Category: Immunosuppressant
  • Primary Medical Use: Prevention of organ rejection after transplantation
  • Route: Oral
  • Prescription: Required
  • Manufacturer/Marketer: Zydus Lifesciences / Zydus Cadila listings in India
  • Typical Packaging: Strip of 10 tablets, depending on market and pack configuration
  • Storage: Follow the storage conditions printed on the product packaging.

3. Uses of MYCOMUNE-S 360 MG

MYCOMUNE-S 360 MG is mainly used to help prevent rejection of a transplanted organ. It may be prescribed as part of combination immunosuppressive therapy following transplantation, including kidney, heart, or liver transplantation depending on the physician's treatment protocol.

The exact indication, dose, and combination with other medicines must be determined by the treating transplant physician.

4. Benefits of MYCOMUNE-S 360 MG

The principal therapeutic benefit is reducing the risk of immune-mediated organ rejection following transplantation.

By reducing specific immune-cell activity, mycophenolate helps prevent the immune system from treating the transplanted organ as foreign tissue. This can support the long-term functioning of the transplanted organ when used as prescribed with the patient's other anti-rejection medicines.

5. Side Effects of MYCOMUNE-S 360 MG

Because MYCOMUNE-S suppresses the immune system, it can increase susceptibility to infections and may affect blood-cell counts.

Possible adverse effects include:

  • Diarrhea
  • Nausea
  • Vomiting
  • Abdominal discomfort or pain
  • Headache
  • Anemia
  • Reduced white blood-cell counts
  • Increased risk of bacterial, viral, or fungal infections
  • Fever
  • Urinary tract infections
  • Edema/swelling
  • Indigestion
  • Constipation
  • Increased creatinine levels
  • Tremors
  • Back or muscle pain

Seek medical attention promptly for symptoms suggesting a serious infection, unusual bleeding, severe weakness, or other significant or persistent reactions.

6. Common Side Effects

Some commonly reported effects include:

  1. Diarrhea
  2. Nausea
  3. Vomiting
  4. Headache
  5. Abdominal pain
  6. Indigestion
  7. Constipation
  8. Anemia
  9. Reduced white blood-cell count
  10. Fever
  11. Swelling
  12. Increased susceptibility to infections

Not every patient experiences these effects. Patients should discuss persistent or troublesome symptoms with their physician.

7. How to Use MYCOMUNE-S 360 MG

  • Take MYCOMUNE-S exactly as prescribed by your doctor.
  • Swallow the tablet whole with water.
  • Do not crush, chew, or break the tablet unless specifically instructed by a healthcare professional.
  • Take it at the same time each day to maintain a consistent treatment schedule.
  • Follow your physician's instructions regarding food because instructions may depend on the specific mycophenolate formulation.
  • Do not change the dose or stop treatment on your own.
  • If a dose is missed, follow the instructions provided by your transplant team rather than taking an extra dose.

8. How MYCOMUNE-S 360 MG Works

MYCOMUNE-S contains mycophenolate sodium, an immunosuppressive medicine. It reduces the proliferation and activity of certain immune cells involved in the body's rejection response.

This lowers the immune attack against transplanted tissue and helps reduce the possibility of organ rejection.

9. Safety Advice

Prescription use: MYCOMUNE-S 360 MG should only be taken under medical supervision.

Infections: The medicine can weaken the immune response and increase infection risk. Contact your healthcare provider promptly if you develop fever, persistent cough, unusual weakness, or other signs of infection.

Blood tests: Your doctor may recommend regular blood tests to monitor blood-cell counts and other parameters during treatment.

Pregnancy: Mycophenolate medicines can cause serious fetal harm and increase the risk of miscarriage. Women who can become pregnant require specific pregnancy-prevention measures and medical counselling before and during treatment.

Vaccinations: Because immune function is suppressed, discuss vaccinations with your doctor before receiving them.

Liver/kidney problems: Tell your doctor about existing liver or kidney problems so treatment can be appropriately monitored.

Drug interactions: Inform your physician about all prescription medicines, over-the-counter medicines, supplements, and herbal products you take.

Do not stop treatment suddenly: Transplant medicines are important for preventing rejection. Any change should be made by the transplant specialist.

10. Frequently Asked Questions (FAQs)

Q1. What is MYCOMUNE-S 360 MG used for?

It is primarily used as an immunosuppressant to help prevent rejection of a transplanted organ.

Q2. What is the active ingredient in MYCOMUNE-S 360 MG?

Current Indian medicine references list mycophenolate sodium 360 mg as the active ingredient.

Q3. Is MYCOMUNE-S 360 MG a prescription medicine?

Yes. It is a prescription immunosuppressant and should be used under appropriate medical supervision.

Q4. Can I stop MYCOMUNE-S when I feel better?

No. Transplant patients should never stop or modify immunosuppressive treatment without consulting their transplant physician because doing so can increase the risk of organ rejection.

Q5. Does MYCOMUNE-S increase infection risk?

Yes. Since it suppresses immune activity, patients can be more susceptible to infections.

Q6. Does MYCOMUNE-S require blood tests?

Doctors commonly monitor patients with blood tests, including blood-cell counts, during treatment.

Q7. Can MYCOMUNE-S be taken during pregnancy?

Mycophenolate can cause serious harm to an unborn baby and is associated with miscarriage. Pregnancy planning and contraception must be discussed with the treating physician.

Q8. Can MYCOMUNE-S be taken with other medicines?

It is commonly used as part of a combination immunosuppressive regimen, but potential interactions must be assessed by the physician.

Q9. What should I do if I experience a fever while taking MYCOMUNE-S?

Contact your doctor or transplant team promptly because fever may indicate an infection in an immunosuppressed patient.

Q10. Can MYCOMUNE-S 360 MG be substituted with another brand?

Several products containing comparable mycophenolate formulations are listed as alternatives, but substitution should not be made independently. The exact formulation and strength should be confirmed by a physician or pharmacist.

11. Substitute for MYCOMUNE-S 360 MG

Examples of products listed as alternatives to MYCOMUNE-S 360 MG include:

  • Mycept-S 360 Tablet
  • Mycofit-S 360 Tablet
  • Mofilet-S 360 Tablet
  • Renodapt-S 360 Tablet
  • Mofetyl-S 360 Tablet

Important: These should not be treated as automatic replacements. Different mycophenolate products may contain different formulations, and the treating physician should confirm the appropriate equivalent before switching.

12. SEO Keywords

Primary Keywords

  • MYCOMUNE S 360 MG Tablets
  • MYCOMUNE-S 360 MG Tablet
  • Mycomune S 360 mg exporter
  • Mycomune S 360 mg supplier
  • Mycomune S 360 mg pharmaceutical exporter
  • Mycomune S 360 mg medicine exporter
  • Mycomune S 360 mg tablets supplier from India
  • Mycomune S 360 mg exporter from India
  • Mycophenolate sodium 360 mg tablets
  • Mycophenolate sodium 360 mg exporter

Long-Tail B2B Keywords

  • MYCOMUNE S 360 MG tablets exporter from Nagpur India
  • MYCOMUNE-S 360 MG pharmaceutical supplier from India
  • MYCOMUNE S 360 MG tablets wholesale supplier India
  • Mycophenolate sodium 360 mg tablets exporter from India
  • Mycomune S 360 mg medicine supplier for international buyers
  • Mycomune S 360 mg pharmaceutical products exporter India
  • MYCOMUNE-S 360 MG tablets supplier for USA buyers
  • MYCOMUNE-S 360 MG tablets supplier for UK buyers
  • MYCOMUNE-S 360 MG tablets supplier for Australia
  • MYCOMUNE-S 360 MG tablets supplier for Singapore
  • MYCOMUNE-S 360 MG tablets supplier for Canada
  • MYCOMUNE-S 360 MG tablets supplier for South Korea
  • MYCOMUNE-S 360 MG tablets supplier for UAE
  • Mycophenolate sodium 360 mg wholesale pharmaceutical supplier
  • Mycomune S 360 mg transplant medicine exporter India
  • Mycomune S 360 mg immunosuppressant medicine supplier
  • Mycomune S 360 mg organ transplant medicine exporter
  • Mycomune S 360 mg prescription medicine exporter India
  • Mycomune S 360 mg genuine pharmaceutical supplier India
  • Mycomune S 360 mg bulk medicine supplier India

Phoenix Exim SEO Keywords

  • Phoenix Exim Mycomune S 360 mg exporter
  • Phoenix Exim pharmaceutical exporter Nagpur India
  • Phoenix Exim Mycophenolate sodium 360 mg supplier
  • Phoenix Exim transplant medicine exporter India
  • Phoenix Exim immunosuppressant medicine supplier
  • trusted pharmaceutical exporter from Nagpur India
  • Indian pharmaceutical exporter for international buyers
  • prescription medicine exporter from India
  • pharmaceutical medicine supplier India to USA UK Australia
  • pharmaceutical exporter India to Singapore Canada Korea UAE
Aug 19th, 2026 3:43 PM

Keywords